Elite Trades From Anywhere

$100 Off Your First Year

00
Days
00
Hours
00
Mins
00
Sec
Claim Now
Last Close
104.22
Jul 01 • 02:45PM ET Dollar change+0.77 Percentage change(0.74%)
Index
S&P 500
Market Cap
132.97B
Enterprise Value
199.68B
Income
2.93B
Sales
407.94B
Book/sh
60.85
Cash/sh
9.26
Employees
300000
IPO
Oct 01, 1952
P/E
45.76
Forward P/E
12.42
PEG
0.98
P/S
0.33
P/B
1.71
P/C
11.25
P/FCF
17.98
EV/EBITDA
11.18
EV/Sales
0.49
Quick Ratio
0.66
Current Ratio
0.87
Debt/Eq
1.01
LT Debt/Eq
0.95
Option/Short
Yes / Yes
EPS (ttm)
2.28
EPS next Y
8.39
EPS next Q
1.83
EPS this Y
9.93%
EPS next Y
13.08%
EPS next 5Y
12.65%
EPS past 3/5Y
-24.70% -23.94%
Sales past 3/5Y
7.60% 8.40%
EPS Y/Y TTM
-45.09%
Sales Y/Y TTM
7.68%
EPS Q/Q
63.49%
Sales Q/Q
6.17%
Insider Own
0.16%
Insider Trans
-62.77%
Inst Own
90.39%
Inst Trans
-1.34%
ROA
1.15%
ROE
3.80%
ROIC
1.94%
Gross Margin
13.88%
Oper. Margin
3.26%
Profit Margin
0.72%
SMA20
4.18%
SMA50
12.24%
SMA200
28.01%
Trades
Shs Outstand
1.28B
Shs Float
1.27B
52W High
106.15 -1.82%
52W Low
58.50 78.15%
Volatility
2.18% 2.34%
ATR (14)
2.38
RSI (14)
69.25
Beta
0.60
Rel Volume
0.51
Avg Volume
8.30M
Volume
3,475,034
Perf Week
2.30%
Perf Month
15.00%
Perf Quarter
45.11%
Perf Half Y
30.24%
Perf YTD
31.32%
Perf Year
49.78%
Perf 3Y
50.75%
Perf 5Y
26.75%
Perf 10Y
9.70%
Prev Close
103.45
Price
104.22
Change
0.74%
Date Action Analyst Rating Change Price Target Change
Mar-12-26Upgrade Bernstein Mkt Perform → Outperform $94
Oct-14-25Initiated Goldman Buy $91
Aug-18-25Upgrade UBS Neutral → Buy $79
Aug-14-25Upgrade Robert W. Baird Neutral → Outperform $82
Feb-13-25Upgrade Leerink Partners Market Perform → Outperform $55 → $75
Feb-12-25Upgrade Cantor Fitzgerald Neutral → Overweight
Jan-30-25Upgrade Edward Jones Hold → Buy
Dec-03-24Upgrade Deutsche Bank Hold → Buy $66
Nov-18-24Upgrade Wells Fargo Equal Weight → Overweight $60 → $66
Oct-10-24Upgrade Barclays Equal Weight → Overweight $63 → $82
Today 05:19AM
Jun-30-26 10:52AM
Jun-26-26 06:10AM
Jun-25-26 10:08AM
09:40AM
09:00AM Loading…
09:00AM
09:00AM
Jun-24-26 11:35AM
08:35AM
08:09AM
07:01AM
Jun-23-26 06:01PM
05:33PM
Jun-22-26 08:00AM
Jun-18-26 01:59PM
05:30AM Loading…
Jun-17-26 05:30AM
Jun-16-26 11:44AM
07:23AM
Jun-12-26 12:36PM
Jun-10-26 03:39PM
09:00AM
Jun-09-26 06:41AM
Jun-07-26 07:35PM
Jun-05-26 04:35PM
04:20PM
Jun-04-26 12:38PM
May-29-26 10:22AM
08:00AM
May-28-26 06:14PM
06:07PM
04:01PM Loading…
04:01PM
03:41PM
03:08PM
02:08PM
02:07PM
01:55PM
12:54PM
12:37PM
08:50AM
07:30AM
07:30AM
07:20AM
07:09AM
06:49AM
06:45AM
May-27-26 07:14AM
05:10AM
May-26-26 09:00AM
May-22-26 05:54PM
05:00AM
May-21-26 04:15PM
03:19PM
09:00AM
May-20-26 03:47PM
08:30AM
07:15AM
May-19-26 03:50PM
May-18-26 08:30AM
08:17AM
May-14-26 08:00AM
01:30AM
May-13-26 04:00PM
08:00AM
May-12-26 06:02AM
May-07-26 10:19AM
08:17AM
May-06-26 11:48AM
11:06AM
08:15AM
08:15AM
08:12AM
07:14AM
06:36AM
06:30AM
06:30AM
05:27AM
May-05-26 08:00AM
May-02-26 09:16PM
May-01-26 07:56PM
Apr-30-26 03:03PM
01:00PM
03:00AM
Apr-28-26 02:29PM
11:45AM
08:00AM
Apr-27-26 04:00PM
Apr-24-26 08:20AM
07:36AM
07:30AM
Apr-22-26 10:13AM
12:01AM
Apr-21-26 01:54PM
09:36AM
09:17AM
07:23AM
06:40AM
Apr-08-26 05:01PM
10:18AM
06:30AM
05:10AM
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
CEOMr. J. David Joyner CEBS
Executive VP & CFOMr. Brian O. Newman
EVP of Ventures and Chief Experience & Technology OfficerMr. Tilak Mandadi
Executive VP & Group PresidentMr. Prem S. Shah Pharm.D
Executive VP & President of AetnaMr. Steven Hale Nelson M.B.A.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
AGUIRRE FERNANDODirectorMay 20 '26Proposed Sale94.692,263214,283May 22 05:35 PM
ROBBINS LARRYDirectorMay 19 '26Sale94.451,983,538187,341,3086,213,261May 21 05:43 PM
ROBBINS LARRYDirectorMay 20 '26Sale93.821,018,00095,510,8225,195,261May 21 05:43 PM
ROBBINS LARRYDirectorMay 21 '26Sale93.45370,46234,619,0074,824,799May 21 05:43 PM
FARAH ROGER NDirectorMay 21 '26Proposed Sale93.682,817263,886May 21 12:57 PM
Mandadi TilakEVP, Chief Exp & Tech OfficerMay 08 '26Sale89.5869,5516,230,37910,133May 11 05:27 PM
TILAK MANDADIOfficerMay 08 '26Proposed Sale89.5869,5516,230,719May 08 04:36 PM
Finucane Anne A.DirectorAug 20 '25Sale71.027,500532,65022,156Aug 29 04:29 PM
Finucane Anne A.DirectorAug 20 '25Proposed Sale70.977,500532,275Aug 19 06:57 PM